WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc., a clinical-stage life science company developing a portfolio of potent new antibiotics designed to be effective against dangerous, drug-resistant bacteria (including multidrug-resistant (MDR) gram-negative pathogens), today announced that the company’s executives will present at The JMP Securities Healthcare Conference. Tetraphase President and Chief Executive Officer Guy Macdonald and Tetraphase Chief Medical Officer Patrick Horn, M.D., Ph.D. are scheduled to speak at 10:30 a.m. (ET) on Friday, July 13, 2012. The Conference will take place at The Peninsula Hotel New York in New York City.
